Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article. Pak Euro. J. Med & LS 2026, 9 (1), 25-34. https://doi.org/10.31580/pjmls.v9i1.3417.